The article introduces an autonomous, AI-driven continuous manufacturing demonstrator that has been developed by the PIPAc consortium (Bruker, Novalix, Alysophil, and De Dietrich Process Systems). It ...

Eli Lilly’s breast cancer med Verzenio may look like your standard drug tablet—ovular, off-white, emblazoned with the dosage on the front and Lilly’s logo on the reverse—but behind that modest façade ...

SAN DIEGO, CA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Key Takeaways 1.WuXi AppTec's integrated CRDMO ...

MISSISSAUGA, Ontario, April 16, 2026--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the ...

The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to ...

WEST LAFAYETTE, Ind. – The COVID-19 pandemic has created supply chain gaps in critical drug products, especially those needed for the most critical patients in intensive care units across the country.

Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

Amid the chaos of the Covid-19 pandemic, governments across the globe began to worry about whether key medical goods would arrive to their shores on time. Considering the broader trend of rising ...

Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, enhancing continuous manufacturing processes, focusing on specialty APIs for ...